Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Citation:
Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013 Dec;19(13):2927-36.
Principal Investigator: 
Document Type: 
Research Method: